Patent Assignment
Reel/Frame 052608/0021
Change of Name
Recorded: 2020-05-07
Pages: 19
Assignor
ARROWHEAD RESEARCH CORPORATION
Executed: 2016-04-05
Assignee
ARROWHEAD PHARMACEUTICALS, INC.
177 EAST COLORADO BLVD., SUITE 700, PASADENA, CALIFORNIA, 91105
Covered Property
(1)
RNAi Inhibition of Alpha-ENaC Expression
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 7, 2020
From: VAN HEEKE, GINO; HICKMAN, EMMA; DANAHAY, HENRY LUKE
To: NOVARTIS AG
Reel/Frame 052604/0822 →
Assignment of Assignor's Interest
May 7, 2020
From: TAN, PAMELA
To: NOVARTIS AG
Reel/Frame 052604/0846 →
Assignment of Assignor's Interest
May 7, 2020
From: GEICK, ANKE
To: NOVARTIS AG
Reel/Frame 052604/0927 →
Assignment of Assignor's Interest
May 7, 2020
From: VORNLOCHER, HANS-PETER
To: NOVARTIS AG
Reel/Frame 052604/0947 →
Assignment of Assignor's Interest
May 7, 2020
From: NOVARTIS AG
To: ARROWHEAD RESEARCH CORPORATION
Reel/Frame 052605/0001 →
Security Interest
Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →